277
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Family Related Factors and Concurrent Heroin Use in Methadone Maintenance Treatment in China

, , , &

References

  • Beyrer, C., Malinowska-Sempruch, K., Kamarulzaman, A., Kazatchkine, M., Sidibe, M., & Strathdee, S. A. (2010). Time to act: A call for comprehensive responses to HIV in people who use drugs. Lancet, 376, 551–563. doi:10.1016/S0140-6736(10)60928-2
  • Caplehorn, J. R., Bell, J., Kleinbaum, D. G., & Gebski, V. J. (1993). Methadone dose and heroin use during maintenance treatment. Addiction, 88(1), 119–124. doi:10.1111/j.1360-0443.1993.tb02769.x
  • Chen, X., & Fan, R. (2010). The family and harmonious medical decision making: Cherishing an appropriate Confucian moral balance. The Journal of Medicine and Philosophy, 35, 573–586. doi:10.1093/jmp/jhq046
  • Cao, X., Wu, Z., Rou, K., Li, L., Lin, C., & Wang, C. (2014).… the National Working Group on Methadone Maintenance Treatment Program. Retention and its predictors among methadone maintenance treatment clients in China: A six-source cohort study. Drug and Alcohol Dependence, 145, 87–93. doi:10.1016/j.drugalcdep.2014.09.776
  • Cao, X., Wu, Z., Rou, K., Pang, L., Luo, W., Wang, C. .… the National Methadone Maintenance Treatment Working Group. (2012). Characteristics and associated factors of long-term retention for methadone maintenance treatment patients. Zhonghua Yu Fang Yi Xue Za Zhi, 46(11), 995–998.
  • Dole, V. P., & Joseph, H. (1978). Long-term outcome of patients treated with methadone maintenance. Annals of the New York Academy of Sciences, 311, 181–189. doi:10.1111/j.1749-6632.1978.tb16775.x
  • Farré, M., Mas, A., Torrens, M., Moreno, V., & Camí, J. (2002). Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis. Drug and Alcohol Dependence, 65(3), 283–290. doi:10.1016/S0376-8716(01)00171-5.
  • Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003). Methadone maintenance at different dosages for opioid dependence. The Cochrane Database of Systematic Reviews [electronic resource], 3, CD002208.
  • Goehl, L., Nunes, E., Quitkin, F., & Hilton, I. (1993). Social networks and methadone treatment outcome: The costs and benefits of social ties. The American Journal of Drug and Alcohol Abuse, 19(3), 251–262. doi:10.3109/00952999309001617.
  • Haig, T. (2003). Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Canadian HIV/AIDS Policy & Law Review/Canadian HIV/AIDS Legal Network, 8(3), 48.
  • Jiang, H. (1995). Rehabilitation and aftercare of drug abuse. In: Z. N., Jiang (ed.), Heroin addiction and contemporary treatments (pp. 240–258). Beijing: Science Press.
  • Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment (MMT): A review of historical and clinical issues. The Mount Sinai Journal of Medicine, New York, 67, 347–364.
  • Ling, W., Blakis, M., Holmes, E. D., Klett, C. J., & Carter, W. E. (1980). Restabilization with methadone after methadyl acetate maintenance. Archives of General Psychiatry, 37(2), 194–196. doi:10.1001/archpsyc.1980.01780150084009.
  • Liu, E., Wu, Z., Liang, T., Shen, L., Zhong, H., Wang, B., & Roger, D. (2008). Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China. Zhonghua Yu Fang Yi Xue Za Zhi, 42, 875–878.
  • Luo, W., Wu, Z., & Wei, X. (2010). Reliability and validity of the Chinese version of the Addiction Severity Index. Journal of Acquired Immune Deficiency Syndromes, 53(Suppl), S121–S125. doi:10.1097/QAI.0b013e3181c7dfca
  • Lin, C., Wu, Z., & Detels, R. (2011). Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health, 125(5), 269–274. doi:10.1016/j.puhe.2011.01.009
  • Lin, C., Wu, Z., Rou, K., Yin, W., Wang, C., Shoptaw, S., & Detels, R. (2010). Structural-level factors affecting implementation of the methadone maintenance therapy program in China. Journal of Substance Abuse Treatment, 38, 119–127. doi:10.1016/j.jsat.2009.09.002.
  • Liu, H., Li, J., Lu, Z., Liu, W., & Zhang, Z. (2010). Does Chinese culture influence psychosocial factors for heroin use among young adolescents in China? A cross-sectional study. BMC Public Health, 10, 563. doi:10.1186/1471-2458-10-563
  • Li, L., Lin, C., Wan, D., Zhang, L., & Lai, W. (2012). Concurrent heroin use among methadone maintenance clients in China. Addictive Behaviors, 37(3), 264–268. doi:10.1016/j.addbeh.2011.11.004
  • Luo, X., Zhao, P., Gong, X., Zhang, L., Tang, W., Zou, X., & Ling, L. (2016). Concurrent heroin use and correlates among methadone maintenance treatment clients: a 12-month follow-up study in Guangdong Province, China. International Journal of Environmental Research and Public Health [electronic resource], 13(3), 305. doi:10.3390/ijerph13030305.
  • McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., … Argeriou, M. (1992). The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199–213. doi:10.1016/0740-5472(92)90062-S.
  • Muller, J. K., & Desmond, B. (1992). Ethical dilemmas in a cross-cultural context. A Chinese example. Western Journal of Medicine, 157(3), 323–327.
  • Magura, S., Nwakeze, P. C., & Demsky, S. Y. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93(1), 51–60. doi:10.1046/j.1360-0443.1998.931516.x.
  • Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003). Buprenorphine versus methadone maintenance therapy: A randomized double blind trial with 405 opioid-dependent patients. Addiction, 98, 441–452. doi:10.1046/j.1360-0443.2003.00335.x.
  • Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K., & Wu, Z. (2007). Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS, 21, s103–s107. doi:10.1097/01.aids.0000304704.71917.64
  • Raffa, J. D., Grebely, J., Tossonian, H., Wong, T., Viljoen, M., Khara, M., … Conway, B. (2007). The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug and Alcohol Dependence, 89(2–3), 306–309. doi:10.1016/j.drugalcdep.2007.02.007.
  • Rowan-Szal, G. A., Chatham, L. R., & Simpson, D. D. (2000). Importance of identifying cocaine and alcohol dependent methadone clients. The American Journal on Addictions, 9(1), 38–50. doi:10.1080/10550490050172218.
  • Sofuoglu, M., Gonzalez, G., Poling, J., & Kosten, T. R. (2003). Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. The American Journal of Drug and Alcohol Abuse, 29(4), 713–727. doi:10.1081/ADA-120026256.
  • Sullivan, S. G., Wu, Z., Cao, X., Liu, E., & Detels, R. (2014) & National Methadone Maintenance Treatment Working Group. Continued drug use during methadone treatment in China: A retrospective analysis of 19,026 service users. Journal of Substance Abuse Treatment, 47(1), 86–92. doi:10.1016/j.jsat.2013.12.004
  • Tang, Y., & Hao, W. (2007). Improving drug addiction treatment in China. Addiction, 102, 1057–1063.
  • UNAIDS. (2015). China AIDS Response Progress Report. (2015). Retrieved from http://www.unaids.org/sites/default/files/country/documents/CHN_narrative_report_2015.pdf.
  • Wan, D. (2012). Partnership Status, Continued Drug Use and Treatment Adherence among Newly Enrolled Methadone Maintenance Therapy Patients in China. (Doctoral dissertation). Los Angeles, California, USA: University of California at Los Angeles. Retrieved from http://escholarship.org/uc/item/38v5826j#page-2.
  • Zhao, M., Li, X., Wang, Z. C., Xu, D., & Zhang, M. Y. (2004). The risk factors related to relapse of heroin dependent patients in correction camp. Chinese Journal of Traditional & Western Medicine, 5(16), 1704–1705.
  • Zou, X., Ling, L., & Zhang, L. (2015). Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment program in China: A 7-source retrospective cohort study. BMJ Open, 5, e8162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.